INTRODUCTION
Drug overdose deaths are increasing in number: there were 70,237 U.S. drug overdose deaths in 2017 compared to 63,632 in 2016; the latter a 21.4% increase from 2015 and two-thirds involved an opioid.1 Non-fatal overdoses far exceed the number of overdose deaths.2 To develop a public health response to opioid-related morbidity, researchers and policymakers are looking upstream to prevent first opioid exposure, long-term opioid use, and diversion. The first exposure to opioids is usually from a prescription or prescription diversion and larger quantities, higher dosages and longer duration play a significant role in later opioid use.3–8
Dental clinicians’ prescribing of opioids appears to account for between 5% and 10% of all opioid prescriptions.9–13 Many pills from dental opioid prescriptions go unused 14 and the necessity for opioids rather than other analgesics for dental and other surgeries has been questioned in recent studies.15,16 Supporting this contention, prescriptions written by U.S. dentists for opioids are 37 times greater than the proportion written by English dentists.17 Studies have found substantial variation in opioid prescribing between different geographic regions or states and this variation has raised concerns about overprescribing; however, there is no literature on variation among dental providers.18
This study is the first to focus on dental clinicians’ prescribing of opioids for service members in the US Military Health System (MHS). The MHS possesses unique features for a dental study: there is a centralized computerized pharmacy record; soldiers are universally covered for medical and dental care; there are regular dental exams to prevent dental emergencies during deployment; a dental encounter record is part of the medical record system, and centralized policies are promulgated, including following CDC guidelines on opioid prescribing. These features permit this study to compare military dental practices with published findings on civilian practices and to address limitations we identified in prior dental literature related to matching opioid prescriptions to dental encounters, assigning dental opioids to surgical versus non-surgical encounters, and selected samples that may not be generalizable to the studied population.10,19,20
The current study provides new information on this urgent and important public health issue. Using recent data, it updates estimates of prior dental studies conducted in civilian settings, separately examines opioid prescribing for dental extractions versus other surgical or invasive procedures, examines differences between younger and older age-group soldiers, and differences between early and later time periods. We advance knowledge on variation in dental prescribing by also comparing opioid prescribing rates among parent facilities of dental clinics.
METHODS
Design and Setting:
This retrospective secondary data analysis examines dental encounter records and filled opioid prescriptions from October 2008 to Sept 2017 for a sample of US Army soldiers who comprise the SUPIC study cohort. The Dental Program of the MHS operates 270 dental clinics in the US, US territories, and military bases in Europe, the Pacific, and Asia for active duty service members only.
Participants:
The SUPIC study is a longitudinal study of all active duty and activated reserve component Army soldiers (n=865,460) who returned from a deployment as part of Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND) between fiscal years (October to September) 2008 and 2014.21 No data on military family members were obtained. Any sample member who had a Dental Program encounter during the study window, whether before or after their deployment, was eligible for inclusion. We defined the study’s participants as sample soldiers with one or more procedures performed by dentists that were surgical or invasive (hereafter, surgical) and therefore might be associated with an opioid prescription. Our methods to select procedure codes are described in the Appendix Methods. All procedures performed by non-dentists, providers who do not prescribe opioids, were excluded. We rolled up all included procedure records to the encounter level for matching to prescription claims and for analysis. We examined all the prescription claims of the sample and selected for inclusion opioid prescriptions using the Centers for Disease Control algorithm modified to remove opioids that are used to treat addiction disorders.22,23 (See Appendix Methods)
The study protocol was reviewed and approved by the Institutional Review Boards (IRB) of Brandeis University and the Uniformed Services University/Department of Defense.
Outcomes:
Our primary outcome was an encounter with opioid exposure. We specified a 60-day window around each surgical encounter and matched all opioid prescriptions written by a dentist on the date of a surgical encounter, or pre-surgery (within 30 days prior), or post-surgery (within 30 days after surgery). A dental encounter with one or more pre-or post-surgery opioid prescriptions was classified as an opioid-exposed encounter. A second measure of opioid exposure was based on total morphine milligram equivalents (MME) dispensed for the dental encounter during the 60-day window (see Appendix Methods)23 with dental encounters classified as more than 100 MME (yes/no), an equivalent to the typical 5-day supply found in the literature. To further characterize opioid exposure, we examined mean MME, mean days-supply, and frequency by opioid subclass for young and older patient groups.
Covariates:
We defined covariates at two levels, the encounter level and the facility level. The encounter level variables were: types of surgical procedure (endodontic, periodontic, implant, oral & maxillofacial excluding extraction, dental extraction, emergency palliative care), type of dentist (general dentist vs specialist), patient age group at time of encounter (under 26, 26 and older), military rank (junior enlisted, senior enlisted, officer, warrant officer), gender, fiscal year of encounter, and patient’s opioid status at time of encounter (naïve yes/no defined as no filled opioid prescription in the past 90 days). We identified the ‘parent’ military treatment facility for each dental clinic and aggregated encounters to the facility level because of insufficient sample size of most dental clinics. We defined facility-level variables in two groups. First were facility characteristics: region or outside the continental US, facility type (medical center, hospital, clinic or other), and percentage of dental surgeries for young patients (under age 26). Second, we computed dental practice variables at the facility-level: proportion of surgeries for extractions, proportion of surgeries for periodontic procedures, and the proportion of dentists that were specialists.
Statistical methods:
Descriptive analysis was conducted on dental surgical encounters for the full study window (i.e., Main Study). We present the percentage of surgical encounters that resulted in opioid exposure and greater than 100 MME for patient subgroups and types of encounters. We separately examined dental extraction encounters and all other surgical encounters as some prior literature has focused on extractions. To address policymaker interest, we compared the proportion of all opioids prescribed for dental surgical procedures for early (2008–2013) and recent (2014–2017) time periods. To address our core question about the degree of variation between facilities, we nested dental encounters within specific facilities to examine variation in prescribing rates between facilities. For these analyses, we restricted the data to October 2014 to September 2017 (Facility study). Dentists in the military’s Dental Program move among facilities every three years or so and by restricting study years we attempted to stabilize the pool of dentists at each facility.
We first calculated the observed opioid prescribing rates for dental extractions and other surgical encounters; we present these data for the 30 facilities with the largest volume of dental encounters. We then performed multivariate analysis to estimate the variation in opioid prescribing within and among facilities due to encounter-level variables (within facility) or context/facility-level variables (between facilities). We used a two-level multilevel model, using the STATA command melogit estat ICC. In the Appendix Methods we present supplementary analysis that compares the observed to the expected opioid prescribing rate for facilities with at least 25 encounters which takes into account the facility case mix.
Statistical significance was defined at the p<.01 level. Analyses were performed using SAS 9.4 and STATA 15 procedures.
RESULTS
Dental Opioids Overview
Among all soldiers eligible for the study (n=865,460), nearly all (n=819,453) had at least one military Dental Program encounter and 317,128 dental patients (38.7%) had at least one surgical encounter during the study window of October 2008 to September, 2017. There were 743,459 surgical encounters, thus each dental patient with a surgical encounter had on average 2.3 surgical encounters. There were 4,472 dentists who performed these surgical procedures (Figure 1, Flow Diagram).
Figure 1:
Flow Diagrams: Main study and facility substudy
There were 4,109,048 opioid prescriptions filled by the sample for any purpose during the study window, of which 342,595 prescriptions were linked to a Dental Program surgical or non-surgical encounter (8.3%). Among the 580,599 soldiers who received an opioid prescription, 195,035 (33.6%) received at least one dental opioid prescription and 88.7% of dental prescriptions were for surgical procedures (Figure 1).
To compare time trends we examined changes within two age groups (Table 1). We hypothesized apriori that younger patients were more likely to have opioid prescriptions from dental encounters than older patients but we note that, because of the longitudinal cohort design, the sample aged over the study. Of all opioid prescriptions filled by younger patients, 16.5% were written by dentists in the earlier period compared to 6.9% of older patients. The percentage of opioids written by the Dental program declined for both age groups in the later period (p <.001).
Table 1.
Percent of total opioid prescriptions attributable to the Dental Program in study sample
| Sample and time period a | Opioid prescriptions for study sample | |||
|---|---|---|---|---|
| Total prescriptions (A) | Dental program prescriptionsc | |||
| N | N | % of total (A) | ||
| Under age 26, all years | 848,760 | 138,085 | 16.3% | |
| 2009–2014b | 780,188 | 129,037 | 16.5% | |
| 2015–2017 | 59,524 | 9,048 | 15.2% | |
| Age 26+, all years | 3,260,288 | 204,510 | 6.3% | |
| 2009–2014b | 2,208,011 | 153,032 | 6.9% | |
| 2015–2017 | 1,062,277 | 51,478 | 4.9% | |
| All ages, all years | 4,109,048 | 342,595 | 8.3% | |
| 2009–2014 | 2,988,199 | 282,069 | 9.4% | |
| 2015–2017 | 1,120,849 | 60,526 | 5.4% | |
Notes:
Years are fiscal years; i.e., 2009 starts October 1, 2008.
A multiple logistic regression on proportion of opioid prescriptions found that the indicator variables for age group and time period and the interaction term of agegroup * timeperiod, were each significant, p<.001.
Includes surgical and non-surgical dental opioid prescriptions.
Table 2 presents a description of all surgical encounters for the dental sample and the rate of opioid prescribing. One-third of encounters were made by patients under the age of 26, the vast majority of encounters were among male and enlisted patients, nearly one-half were among racial/ethnic groups other than white, and over 80% were opioid naïve (no opioid prescription fill in the prior 90 days) at the time of the encounter. The most frequent types of procedures were endodontic and dental extraction. Eighty-four percent (84%) of the encounters were to general dentists rather than specialists, and nearly one-half of the encounters were at dental clinics associated with a medium-size military treatment facility.
Table 2.
Characteristics of dental encounters by opioid exposure, October 2008 – September 2017
| Encounter Characteristic | # of surgical encounters | % of surgical encounters (SE) | With opioid prescription (OP) | With total opioid dose > 100 MME | ||
|---|---|---|---|---|---|---|
| N | % of SE | N | % of OP | |||
| Total Surgical Encounters a | 743459 | 100.0 | 272718 | 36.7 | 138346 | 50.7 |
| Age group | ||||||
| 26+ | 471739 | 63.5 | 161323 | 34.2 | 76633 | 47.5 |
| <26 | 271720 | 36.6 | 111395 | 41.0 | 61713 | 55.4 |
| Sex | ||||||
| Female | 101651 | 13.7 | 35882 | 35.3 | 17445 | 48.6 |
| Male | 641808 | 86.3 | 236836 | 36.9 | 120901 | 51.0 |
| Rank | ||||||
| Enlisted | 653126 | 87.8 | 245096 | 37.5 | 125473 | 51.2 |
| Officer | 90333 | 12.2 | 27622 | 30.6 | 12873 | 46.6 |
| Race Ethnicity | ||||||
| Non-Hispanic, Asian or Pacific Islander | 79388 | 10.7 | 29915 | 37.7 | 15411 | 51.5 |
| Non-Hispanic, Black | 166843 | 22.4 | 62414 | 37.4 | 31642 | 50.7 |
| Hispanic | 80796 | 10.9 | 32176 | 39.8 | 16796 | 52.2 |
| Non-Hispanic, White | 401485 | 54.0 | 142986 | 35.6 | 71982 | 50.3 |
| American Indian, Alaskan Native or other | 14947 | 2.0 | 5227 | 35.0 | 2515 | 48.1 |
| Componentb | ||||||
| Active duty | 565551 | 90.5 | 216329 | 37.1 | 11,308 | 51.0 |
| National Guard | 38443 | 6.1 | 9749 | 25.3 | 4195 | 43.0 |
| Reserve | 20559 | 3.3 | 5686 | 27.6 | 2482 | 43.7 |
| Patient opioid status time of encounterc | ||||||
| Naïve | 502941 | 80.5 | 169157 | 33.6 | 86673 | 51.2 |
| Not naïve | 121735 | 19.5 | 62630 | 51.4 | 30323 | 48.4 |
| Type of surgical procedure (not mutually exclusive)d | ||||||
| Endodontic | 357189 | 48.0 | 38118 | 10.7 | 9812 | 25.7 |
| Periodontic | 56057 | 7.5 | 41485 | 74.0 | 19268 | 46.4 |
| Implant | 46550 | 6.3 | 18976 | 40.8 | 10533 | 55.5 |
| Oral & Maxillofacial (excl. extraction) | 46977 | 6.3 | 24860 | 52.9 | 13626 | 55.0 |
| Dental Extraction | 203559 | 27.4 | 165757 | 81.4 | 96192 | 58.0 |
| Palliative Emergency | 78019 | 10.5 | 14997 | 19.2 | 5148 | 34.3 |
| By Provider Type | ||||||
| Oral Surgeon | 50226 | 6.8 | 43270 | 86.2 | 30362 | 70.2 |
| Periodontist | 17839 | 2.4 | 13671 | 76.6 | 5362 | 39.2 |
| Prosthodontist | 11090 | 1.5 | 1033 | 9.3 | 393 | 38.0 |
| Orthodontist | 1066 | 0.1 | 143 | 13.4 | 65 | 45.5 |
| Oral Pathologist | 689 | 0.1 | 264 | 38.3 | 21 | 7.9 |
| Endodontist | 36738 | 4.9 | 7905 | 21.5 | 1310 | 16.6 |
| Dental Officer General | 624319 | 84.0 | 206034 | 33.0 | 100688 | 48.9 |
| Pedodontist | 1492 | 0.2 | 398 | 26.7 | 145 | 36.4 |
| By Opioid Subclass | ||||||
| Codeine | 17625 | 6.5 | 17625 | 100.0 | 73 | 0.04 |
| Hydrocodone | 68352 | 25.1 | 68352 | 100.0 | 12622 | 18.5 |
| Oxycodone | 183888 | 67.4 | 183888 | 100.0 | 123355 | 67.1 |
| Tramadol | 1912 | 1.0 | 1912 | 100.0 | 880 | 46.0 |
| Other | 941 | < 1.0 | 941 | 100.0 | 173 | 18.4 |
| Facility Service Branch | ||||||
| Army | 633913 | 85.3 | 248415 | 39.2 | 127014 | 51.1 |
| Other branch | 20815 | 2.8 | 7403 | 35.6 | 3759 | 50.8 |
| Facility Typeassociated with dental clinic | ||||||
| Medical Center (largest) | 185549 | 25.0 | 80050 | 43.1 | 47453 | 59.3 |
| Hospital (medium) | 368098 | 49.5 | 140449 | 38.2 | 74473 | 53.0 |
| Clinic and other (smallest) | 189812 | 25.5 | 52219 | 27.5 | 16420 | 31.4 |
| Facility Regione | ||||||
| TRICARE OCONUS | 42544 | 5.7 | 17878 | 42.0 | 5923 | 33.1 |
| TRICARE North | 155063 | 20.9 | 53137 | 34.3 | 21547 | 40.5 |
| TRICARE South | 255779 | 34.4 | 94401 | 36.9 | 49903 | 52.9 |
| TRICARE West | 215343 | 29.0 | 95120 | 44.2 | 54951 | 57.8 |
| Other / Unknown | 74730 | 10.1 | 12182 | 16.3 | 6022 | 49.4 |
Notes:
Note: number of encounters with opioids is less than total number of dental opioids (Table 1) because each encounter may be associated with more than one opioid prescription.
Total includes 123 encounters where component at time of the encounter was not recorded.
Opioid naïve defined as no opioid prescription fills for any purpose in the 90 days prior to the dental encounter.
Includes palliative emergency and invasive procedures that are not surgical but we hypothesized would account for some opioid prescriptions.
States included in TRICARE regions: North= Connecticut, Delaware, the District of Columbia, Illinois, Indiana, Kentucky, Maine, Maryland, Massachusetts, Michigan, New Hampshire, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Vermont, Virginia, West Virginia, Wisconsin and portions of Iowa (Rock Island Arsenal area), Missouri (St. Louis area) and Tennessee (Ft. Campbell area); South = Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, Oklahoma, South Carolina, Tennessee (excluding the Ft. Campbell area) and Texas (excluding the El Paso area); West = Alaska, Arizona, California, Colorado, Hawaii, Idaho, Iowa (excluding Rock Island Arsenal area), Kansas, Minnesota, Missouri (except the St. Louis area), Montana, Nebraska, Nevada, New Mexico, North Dakota, Oregon, South Dakota, Texas (the southwestern corner, including El Paso), Utah, Washington and Wyoming; OCONUS (outside continental US) = Hawaii, Guam, Puerto Rico, Europe, Asia, Pacific
All chi-square values for crosstabulations of each characteristic by opioid prescription and each characteristic by dose > 100 MME given an opioid prescription, are significant at p < .001
More than one-third of surgical encounters (36.7%) resulted in an opioid fill and for one-sixth of surgical encounters (18.6%) the total opioid dose was over 100 MME (Table 2). The percentage of encounters with an opioid and the percentage with higher total dose was larger among young, enlisted, Hispanic soldiers, and for periodontic and dental extraction procedures (all comparisons p < .01). Among these dental prescriptions, 83.1% were written on the same day as a surgical procedure, 13.8% written within 30 days before the surgery, and 3.1% written within 30 days after surgery date (data not on table).
Hydrocodone (25.1%) and oxycodone (67.4%) were the most frequent opioid prescriptions. The median opioid dose was 120 MME for dental extraction encounters and 90 MME for non-extraction surgical encounters, and the median days-supply was 3 (Table 3). Only 4.7% of prescriptions was for 1 day-supply; 24.0% was for 2 days, and 6.3% was for 21 or more days-supply of opioids. Younger soldiers received a higher mean MME than older soldiers for dental extractions, and mean MME for all dental extraction encounters were higher than other dental surgery procedures (Table 3).
Table 3.
Percent distribution on opioid days-supply and average opioid dose per surgical encounter with opioida, October 2008-September 2017
| Non-extract encounters | Encounters with extractions | All surgical encounters | |||||
|---|---|---|---|---|---|---|---|
| 26 & older | Under 26 | All | 26 & older | Under 26 | All | All ages | |
| Sample n | 81,224 | 25,737 | 106,961 | 80,099 | 85,658 | 165,757 | 272,718 |
| Total days-supply | Percent distribution | ||||||
| 1 day | 5.6 | 7.2 | 6.0 | 3.8 | 3.2 | 3.7 | 4.7 |
| 2 | 26.5 | 28.2 | 26.9 | 22.6 | 21.7 | 22.1 | 24.0 |
| 3 | 29.3 | 26.3 | 28.6 | 32.1 | 30.5 | 31.3 | 30.2 |
| 4 | 11.1 | 10.4 | 10.7 | 11.9 | 13.5 | 12.7 | 12.0 |
| 5 | 10.0 | 8.6 | 9.9 | 11.6 | 11.5 | 11.6 | 10.7 |
| 6–10 days | 5.1 | 4.8 | 5.0 | 5.0 | 5.0 | 4.5 | 4.9 |
| 11–20 | 3.2 | 3.0 | 3.1 | 2.7 | 2.6 | 2.6 | 2.8 |
| 21 or more | 8.3 | 9.6 | 8.6 | 7.5 | 8.2 | 7.9 | 8.2 |
| Total MME | Average morphine milligram equivalents | ||||||
| Mean (SD)b | 109 (76) | 104 (74) | 108 (76) | 126 (69) | 134 (59) | 131 (64) | 121 (70) |
| Median | 90 | 90 | 90 | 113 | 150 | 120 | 105 |
| IQR (low, high) | 75, 150 | 60, 120 | 67, 150 | 80, 150 | 90, 150 | 90 150 | 75, 150 |
| Total MME > 100, % yes | 40.5 | 36.0 | 36.2 | 54.6 | 61.2 | 58.0 | 50.7 |
Analysis based on opioid prescriptions that were written on date of surgical encounter or either pre-surgery (within 30 days prior), or post-surgery (within 30 days after surgery). If multiple prescriptions were on the same date or within this 60 day window, days-supply and total MME were summed for all prescriptions.
T-test of difference in means 26 and older relative to under age 26 for non-extraction procedures, unequal variances = 9.3 p < 0.0001; T-test for extraction procedures, unequal variances = −26.3, p<0.001
IQR = interquartile range; the values reported are for the 25th percentile and 75th percentile
MME = morphine milligram equivalents
Facility-specific analysis: October 2014-September 2017
Facility-specific observed prescribing percentages varied by a factor of 30.1 (87.5% vs 2.9%) for facilities with at least 25 observations in the study. Figure 2 shows the difference in prescribing rates among the 30 facilities with the largest volume of surgical procedures, stratified by encounters for extractions vs other surgical procedure. The range of prescribing rates for dental extraction was 60% to 94% and for other surgical encounters was 10% to 29%. In supplemental analysis described in the Appendix Methods, we describe the expected prescribing percentage for each facility with at least 25 observations. Among these facilities, the range remained large (64.7% to 19.0%) after we adjusted for case-mix.
Figure 2.
Percent of dental surgical encounters (non-extraction, top panel; extraction, bottom panel) with opioid prescriptions by facility: top 30 of 130 facilities by encounter volume, October 2014-September 2017
Note: Observed percentage of encounters associated with dental opioid prescription on date of encounter, within 30 days before the surgery, or within 30 days after the surgery. Facilities numbered by total number of surgical encounters (1 = highest). Restricted to top 30 facilities by encounter volume; minimum volume of encounters = 1,968.
In the multilevel multinomial models, the facility-level (Level 2) variables were significant predictors of opioid prescribing after controlling for encounter (Level 1) factors (see Appendix Methods). The multilevel results also showed that facility-level regional variables and facility-level variables that captured the clinical practice behavior explained 80% of the between-facility variation.
DISCUSSION
Clinicians’ decisions regarding the prescription of opioids require a balance between the pain-reducing benefits and the possible adverse short-term (e.g. constipation) and long-term (e.g. habituation) risks. Recommendations of respected organizations urge caution in prescribing opioids. In this context, our finding that some military dental clinics prescribe opioids at a significantly lower rate than other clinics suggests a path to follow. In this retrospective study, we showed facility-specific opioid prescribing percentages varied by a factor of 30, and in supplemental analysis, that dentists at 11 of the 30 largest facilities prescribed at a rate 4 percentage points higher than expected given their case mix, and dentists at nine of these facilities had a rate 4 percentage points lower than expected. Based on this variation among dental clinics, it would be reasonable for dental leadership to compare clinical practices among facilities and attempt to identify the basis for lower reliance on opioid analgesics.
Our study provides comparison with studies in civilian populations. Opioid prescriptions were filled for 36.7% of dental encounters; 50.1% of opioid encounters received more than 100 MME. Dental care accounted for a substantial proportion of all opioid prescriptions in the population, particularly among young patients where it was 16.5% of all opioids in the period October, 2008 to September 2014 and 13.2% in the period starting October, 2014 to September, 2017. A unique aspect of military dentistry is that service members receive a dental readiness classification based on annual exams, thus they had much higher access to dental care than the civilian population. Further, the military pays for all dental care for active duty and activity service members to avoid emergency care and morbidity. In our sample, 4.3% of records had oral conditions classified as expected to result in dental emergencies within 12 months if not treated, 56.8% had oral conditions that if not treated had the potential, but were not expected, to result in dental emergencies within 12 months. This percentage would be higher among service members just starting a military care, reflecting the restricted access to dental care in the US.
The higher rate of opioid prescribing to the under-26 sample (42% versus 34%) is noteworthy, given dental care is often the source of first prescribing in this age group and has been found to increase risk of subsequent opioid use and misuse.19 Eighty percent (80%) of our sample had not filled opioids for any reason in the prior 90 days. The decrease in percent of dental-to-overall opioid prescribing within age group over the study timeframe parallels a decrease seen in the civilian world24 as the overall dental community learned to manage dental pain through non-opioid medications. Of note, dental opioid prescriptions in one Canadian province during the 2014–2017 timeframe were only 3.8% of total opioid prescriptions,25 lower than what we report.
Dental extractions, 27.4% of surgical encounters, accounted for a disproportionate share of opioid-exposure. The rate of opioid exposure for extraction procedures in military clinics (81%) matches the rate (80%) in a civilian study.26 For patients age 26 and over and under 26, dental extractions accounted for 43.3% and 73.6%, respectively, of dental opioids. Of note, the American Association of Oral and Maxillofacial Surgeons recommends NSAID’s as the first-line analgesic for extractions.27
The median days-supply in this study, estimated at 3, matched civilian studies.10 Military dentists were more likely than their civilian counterparts to prescribe oxycodone (67% military; 11% civilian), and less likely to prescribe hydrocodone (25% military; 65% of civilian dental opioid prescriptions), codeine (7% military; 14% civilian), and tramadol (1% military; 5% civilian).10 Expert guidelines do not recommend one short-acting opioid over another 28 and a study found little difference in pain relief between oxycodone/acetaminophen and hydrocodone/acetaminophen.29
We found that younger age, enlisted members, Hispanic patients, and males were more likely than other soldiers to receive an opioid prescription. Contrariwise, one study in the civilian literature found Hispanics less likely than Whites and Blacks more likely than Whites to receive opioid prescriptions;30 while another separate study found no difference between race/ethnic groups.2
Geographic variation in overall prescribing of opioids is well known: the mean per capita MME in the top quartile of US counties was approximately six times the amount prescribed in the lowest quartile.18 To our knowledge there are no published studies of variation in opioid prescribing among dental group practices. One might expect local leadership, shared norms, and instruction of junior dentists by experienced dentists to affect the decisions of individual group practices.
As with all retrospective cohort studies, this study has several limitations. First, we did not account for variation among individual prescribers, which was beyond the scope of this paper. Second, there were unmeasured patient characteristics, for example opioid use disorder. Third, a small number of dental procedures for this sample may have occurred outside of the Dental Program in emergency departments that were not studied here.
The combination of NSAID’s and acetaminophen is superior to opioids for controlling post-dental procedure pain in some studies.31,32 Based on literature, the American Dental Association guidelines recommend screening patients for opioid ‘red flags’ or risk signs and also recommend that dentists consult a state’s prescription drug monitoring program (PDMP) before prescribing.31 Civilian dental practices have had low rates of requesting medical records and rare use of PDMP’s.33 The military health system has advantages here because it integrates dental care into the medical record and a unified prescription record system provides military dental clinicians with readily available information and other flags for possible opioid overuse.
It is difficult to change the behavior of clinicians whose training has been to provide opioids to ameliorate significant pain. The MHS has undertaken many initiatives to address possible over-prescribing, for example the creation of an Opioid Registry in 2017 intended to help clinicians and clinic directors monitor care delivery. There are some signs that their efforts have been successful -- the military’s rate of deadly overdoses is a quarter of the national average.34 However, this study suggests additional strategies may be warranted. Prior research has demonstrated that ‘academic detailing’, or direct outreach education to clinicians, is an effective communication strategy that actually leads to change in practice,35 and it has been successfully tailored to encourage safer opioid prescribing.36,37 Further strategies may be needed to address patient expectations for narcotic pain medication, which can translate into pressure on clinicians.
In conclusion, these findings imply that more attention should be paid to strategies utilized at dental clinics of military facilities achieving lower prescribing rates given nine of the thirty largest facilities demonstrated rates significantly lower than the average. We hope that our evidence that some dental groups can achieve lower levels of opioid prescribing may increase confidence in dental leadership discussions leading to lower rates of opioid prescribing.
Supplementary Material
ACKNOWLEDGEMENTS
Funded by Uniformed Services of the Health Sciences Health Services Research Program (HSRP-87–9549) and the National Center for Complementary and Integrative Health (R01 AT008404). We acknowledge the Axiom Resources Management, Inc. for compiling the data files used in these analyses.
Data sponsorship obtained from the Defense Veterans Complementary and Integrative Pain Management program, with a Data Sharing Agreement from the DoD’s Defense Health Agency Privacy and Civil Liberties Office.
References
- 1.Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and Opioid-Involved Overdose Deaths MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419–1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.CDC’s Enhanced State Opioid Overdose Surveillance (ESOOS) Program, 32 states and the District of Columbia reporting. 2019; https://www.cdc.gov/drugoverdose/data/nonfatal/nonfatal-opioids.html. Accessed January 2, 2020.
- 3.Shah A, Hayes CJ, & Martin BC. Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use — United States, 2006–2015. Morbidity and Mortality Weekly Report. 2017;66(10):265–269. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sun EC, Darnell BD, Baker LC, & Mackey S. Incidence of and Risk Factors for Chronic Opioid Use Among Opioid-Naive Patients in the Postoperative Period. JAMA Internal Medicine. 2016;176(9). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Delgado MK, Huang Y, Meisel Z, Hennessy S, Yokell M, Polsky D, & Perrone J. National Variation in Opioid Prescribing and Risk of Prolonged Use for Opioid-Naive Patients Treated in the Emergency Department for Ankle Sprains. Annals of Emergency Medicine. 2018;72(4):389–400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Deyo RA, Hallvik SE, Hildebran C, Marino M, Dexter E, Irvine JM, … Millet LM. Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naïve Patients: A Statewide Retrospective Cohort Study. Journal of General Internal Medicine. 2016;32:21–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gil JA, Gunaseelan V, DeFroda SF, Brummett CM, Bedi A, & Waljee JF. Risk of Prolonged Opioid Use Among Opioid-Naïve Patients After Common Shoulder Arthroscopy Procedures. The American Journal of Sports Medicine. 2019;47(5):1043–1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Jeffery MM, Hooten W, Hess EP, Meara ER, Ross JS, Henk HJ, … Bellolio MF. Opioid Prescribing for Opioid-Naive Patients in Emergency Departments and Other Settings: Characteristics of Prescriptions and Association With Long-Term Use. Annals of Emergency Medicine. 2018;71(3):326–336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Volkow ND, McLellan TA, Cotto JH, Karithanom M, & Weiss SR. Characteristics of opioid prescriptions in 2009. JAMA. 2011;305(13):1299–1301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gupta N, Vujicic M, & Blatz A. Opioid prescribing practices from 2010 through 2015 among dentists in the United States: What do claims data tell us? The Journal of the American Dental Association. 2018;149(4):237–245. [DOI] [PubMed] [Google Scholar]
- 11.Fink PB, Deyo RA, Hallvik SE, Hildebran C. Opioid Prescribing Patterns and Patient Outcomes by Prescriber Type in the Oregon Prescription Drug Monitoring Program. Pain Med. 2018;19(12):2481–2486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Ringwalt C, Gugelmann H, Garrettson M, Dasgupta N, Chung AE, Proescholdbell SK, Skiner AC. Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses. Pain Res Manag 2014;19(4):179–185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Guy GP Jr, Zhang K. Opioid prescribing by specialty and volume in the US. American journal of preventive medicine. 2018. November;55(5):e153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Maughan BC, Hersh EV, Shofer FS, Wanner KJ, Archer E, Carrasco LR, & Rhodes KV. Unused opioid analgesics and drug disposal following outpatient dental surgery: a randomized controlled trial. Drug and alcohol dependence. 2016;168:328–334. [DOI] [PubMed] [Google Scholar]
- 15.Ashburn MA, Fleisher LA. Increasing evidence for the limited role of opioids to treat chronic noncancer pain. JAMA. 2018;320(23):2427–2428. [DOI] [PubMed] [Google Scholar]
- 16.Busse JW, Li W, Mostafa K, et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. JAMA. 2018;320(23):2448–2460. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Suda KJ, Durkin MJ, Calip GS, Gellad WF, Kim H, Lockhart PB, … & Thornhill MH. Comparison of Opioid Prescribing by Dentists in the United States and England. JAMA network open. 2019;2(5):e194303–e194303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Guy GP Jr, Zhang K, Bohm MK, Losby J, Lewis B, Young R, Murphy LB, Dowell D. Vital Signs: Changes in Opioid Prescribing in the United States, 2006–2015. MMWR Morb Mortal Wkly Rep. 2017;66(26):697–704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Schroeder AR, Dehghan M, Newman TB, Bentley JP, Park K. Association of opioid prescriptions from dental clinicians for US adolescents and young adults with subsequent opioid use and abuse. JAMA internal medicine. 2019;179(2):145–152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Gupta N, Vujicic M, Blatz A. Multiple opioid prescriptions among privately insured dental patients in the United States: evidence from claims data. The Journal of the American Dental Association. 2018;149(7):619–627. e611. [DOI] [PubMed] [Google Scholar]
- 21.Larson MJ, Adams RS, Mohr BA, Harris Harris AH, Merrick E, Funk W, Hofmann K, Wooten NR, Jeffery DD, and Williams TV. Rationale and Methods of a Longitudinal Study of Army Combat Veterans Returning from Deployment FY2008–2011. Substance Use & Misuse. 2013;48(10):863–879. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Adams RS, Thomas C, Ritter GA, Lee S, Saadoun M, Williams TV, Larson MJ. Predictors of Postdeployment Prescription Opioid Receipt and Long-term Prescription Opioid Utilization Among Army Active Duty Soldiers. Military Medicine. 2019;184(1–2):e101–e109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Centers for Disease Control (CDC). Analyzing Prescription Data and Morphine Milligram Equivalents (MME). 2019. https://www.cdc.gov/drugoverdose/resources/data.html.
- 24.Levy B, Paulozzi L, Mack KA, Jones CM. Trends in Opioid Analgesic-Prescribing Rates by Specialty, U.S., 2007–2012. Am J Prev Med. 2015;49(3):409–413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Falk J, Friesen KJ, Magnusson C, Schroth RJ, Bugden S. Opioid prescribing by dentists in Manitoba, Canada: A longitudinal analysis. J Am Dent Assoc. 2019;150(2):122–129. [DOI] [PubMed] [Google Scholar]
- 26.Harbaugh CM, Nalliah RP, Hu HM, Englesbe MJ, Waljee JF, Brummett CM. Persistent opioid use after wisdom tooth extraction. JAMA. 2018;320(5):504–506. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.American Association of Oral and Maxillofacial Surgeons, White Paper. Pain Management Best Practices Inter-Agency Task Force Report: Updates, Gaps, Inconsistencies, and Recommendations. 2019. [Google Scholar]
- 28.U.S. Department of Health and Human Services. Pain Management Best Practices Inter-Agency Task Force Report: Updates, Gaps, Inconsistencies, and Recommendations. 2019; https://www.hhs.gov/ash/advisory-committees/pain/reports/index.html.
- 29.Chang AK, Bijur P, Holden L, Gallagher EJ. Comparative Analgesic Efficacy of Oxycodone/Acetaminophen Versus Hydrocodone/Acetaminophen for Short-term Pain Management in Adults Following ED Discharge. Acad Emerg Med. 2015;22(11):1254–1260. [DOI] [PubMed] [Google Scholar]
- 30.Steinmetz CN, Zheng C, Okunseri E, Szabo A, Okunseri C. Opioid Analgesic Prescribing Practices of Dental Professionals in the United States. JDR Clin Trans Res. 2017;2(3):241–248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.McCauley JL, Leite RS, Gordan VV, Fillingim RB, Gilbert GH, Meyerowitz C, Cochran D, Rindal DB, Brady KT. National Dental Practice-Based Research Network Collaborative Group. Opioid prescribing and risk mitigation implementation in the management of acute pain: Results from The National Dental Practice-Based Research Network. J Am Dent Assoc. 2018;149(5):353–362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.American Dental Association. Substance Use Disorders. 2018; https://www.ada.org/en/advocacy/current-policies/substance-use-disorders.
- 33.Barasch A, Safford NM, McNeal SF, Robinson M, Grant VS, Gilbert GH. Patterns of postoperative pain medication prescribing after invasive dental procedures. Spec Care Dentist. 2011;31(2):53–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Grisales C. Military Making Headway on Opioid Epidemic Among Troops, Officials Say. Military.com. Available at: https://www.military.com/daily-news/2018/06/22/military-making-headway-opioid-epidemic-among-troops-officials-say.html.. [Google Scholar]
- 35.Fischer MA, Avorn J. Academic detailing can play a key role in assessing and implementing comparative effectiveness research findings. Health Affairs. 2012;31(10):2206–2212. [DOI] [PubMed] [Google Scholar]
- 36.Barth KS, Ball S, Adams RS, Nikitin R, Wooten NR, Qureshi ZP, Larson MJ. Development and Feasibility of an academic detailing intervention to improve Prescription Drug Monitoring Program use among physicians. The Journal of continuing education in the health professions. 2017;37(2):98. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Larson MJ, Browne C, Nikitin RV, et al. Physicians report adopting safer opioid prescribing behaviors after academic detailing intervention. Substance abuse. 2018;39(2):218–224. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



